Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Partial Opioid Agonist/Antagonist [EPC]
Pentazocine is a synthetic mixed opioid agonist-antagonist used for the management of moderate to severe pain. It belongs to the benzomorphan class and provides analgesia primarily through kappa-opioid receptor activation.
Name
Pentazocine
Raw Name
PENTAZOCINE
Category
Partial Opioid Agonist/Antagonist [EPC]
Drug Count
3
Variant Count
3
Last Verified
February 17, 2026
RxCUI
312289
UNII
F850569PQR, RP4A60D26L, A36BXO4PPX
About Pentazocine
Pentazocine is a synthetic mixed opioid agonist-antagonist used for the management of moderate to severe pain. It belongs to the benzomorphan class and provides analgesia primarily through kappa-opioid receptor activation.
Detailed information about Pentazocine
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Pentazocine.
Historically, pentazocine represents a significant milestone in pharmacology as it was one of the first "mixed" opioids developed with the intention of providing significant pain relief with a lower risk of respiratory depression and physical dependence compared to pure mu-agonists. However, clinical experience has shown that it still carries risks of addiction, abuse, and misuse. In the United States, pentazocine is classified as a Schedule IV controlled substance under the Controlled Substances Act. It is often prescribed for the relief of moderate to severe pain and is sometimes used as a preoperative medication or as a supplement to surgical anesthesia.
The pharmacological profile of pentazocine is complex and distinct from that of morphine. At the molecular level, pentazocine acts primarily as an agonist at the kappa (κ) opioid receptors and as a weak antagonist or partial agonist at the mu (μ) opioid receptors.
Understanding how the body processes pentazocine is vital for safe administration. The drug undergoes significant first-pass metabolism, which influences its bioavailability and dosing requirements.
According to the FDA-approved labeling, pentazocine is indicated for the following:
Off-label, healthcare providers have occasionally used pentazocine for the management of chronic pain syndromes, though this is less common today due to the availability of newer agents with fewer psychotomimetic side effects.
Pentazocine is available in several formulations, though some brand-name versions have been discontinued in favor of generics or combination products:
> Important: Only your healthcare provider can determine if Pentazocine is right for your specific condition. The choice of formulation and dose depends heavily on the severity of pain and the patient's prior exposure to opioid medications.
Dosage must be individualized based on the patient's pain severity, clinical response, and prior analgesic experience. Healthcare providers typically aim for the lowest effective dose for the shortest duration necessary.
Pentazocine is generally not recommended for use in children under the age of 12. Clinical data regarding the safety and efficacy in pediatric populations are limited. For adolescents over 12, healthcare providers may use adult dosing guidelines with extreme caution and weight-based adjustments, though alternative analgesics are often preferred in this demographic.
Patients with impaired kidney function (reduced glomerular filtration rate) may experience accumulation of pentazocine metabolites. While the parent drug is primarily metabolized by the liver, the kidneys excrete the resulting conjugates. In patients with moderate to severe renal impairment, healthcare providers usually initiate therapy at a lower dose or extend the dosing interval to prevent toxicity.
Since the liver is the primary site of pentazocine metabolism, hepatic dysfunction significantly increases the risk of drug accumulation and overdose. In patients with cirrhosis or hepatitis, the bioavailability of oral pentazocine can increase three-fold. Dosage should be reduced significantly, often by 50% or more, and patients must be monitored closely for signs of central nervous system (CNS) depression.
Older adults are more sensitive to the effects of opioids, particularly the sedative and psychotomimetic (hallucinogenic) effects of pentazocine. Furthermore, age-related declines in renal and hepatic function increase the risk of adverse reactions. Healthcare providers typically start elderly patients on the lowest possible dose and titrate upward very slowly.
If you are taking pentazocine on a regular schedule and miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular timing. Do not double the dose to catch up, as this significantly increases the risk of respiratory depression and overdose.
An overdose of pentazocine is a medical emergency. Signs include extreme somnolence (sleepiness), respiratory depression (slow or shallow breathing), circulatory collapse, and in severe cases, coma or death. Because pentazocine is a mixed agonist-antagonist, it may require larger doses of naloxone (Narcan) to reverse its effects compared to a pure opioid like morphine. If an overdose is suspected, call 911 or emergency services immediately.
> Important: Follow your healthcare provider's dosing instructions precisely. Do not adjust your dose or stop the medication abruptly without medical guidance, as this may lead to withdrawal symptoms.
Pentazocine, like all opioids, affects the central nervous system and the gastrointestinal tract. The most frequently reported side effects include:
> Warning: Stop taking Pentazocine and call your doctor immediately if you experience any of these serious symptoms.
Prolonged use of pentazocine can lead to several chronic issues:
Pentazocine carries several "Black Box Warnings," the most serious alerts issued by the FDA:
Report any unusual symptoms to your healthcare provider promptly to ensure safe management of your pain therapy.
Pentazocine is a potent medication that requires careful medical supervision. It is essential that patients disclose their full medical history to their healthcare provider before starting treatment. Because it is a mixed agonist-antagonist, it behaves differently than standard opioids like oxycodone or morphine, particularly regarding its effect on the heart and its potential to cause withdrawal in opioid-dependent individuals.
The FDA has mandated the following warnings for pentazocine:
Patients on long-term pentazocine therapy require regular monitoring by their healthcare provider:
Pentazocine significantly impairs the mental and physical abilities required for potentially hazardous tasks. Do not drive a car, operate heavy machinery, or engage in activities requiring alertness until you are certain the medication does not make you drowsy, dizzy, or confused. The risk of impairment is significantly increased if pentazocine is combined with alcohol or other sedatives.
Do not consume alcohol while taking pentazocine. Alcohol enhances the central nervous system depressant effects of pentazocine, which can lead to fatal respiratory depression, extreme sedation, and coma. This includes both alcoholic beverages and medications containing alcohol (e.g., some cough syrups).
If you have been taking pentazocine for more than a few days, do not stop taking it suddenly. Abrupt discontinuation can lead to a withdrawal syndrome characterized by restlessness, lacrimation (tearing), rhinorrhea (runny nose), yawning, perspiration, chills, myalgia (muscle pain), and mydriasis (dilated pupils). Your healthcare provider will provide a tapering schedule to gradually reduce the dose and minimize these effects.
> Important: Discuss all your medical conditions, especially respiratory, heart, or liver problems, with your healthcare provider before starting Pentazocine.
Certain medications must never be used with pentazocine due to the risk of life-threatening reactions:
Pentazocine may interfere with certain laboratory tests:
For each major interaction, the management strategy usually involves dose reduction of one or both agents, increased frequency of monitoring, or choosing an alternative medication.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking to avoid dangerous interactions.
In certain circumstances, the risks of pentazocine therapy clearly outweigh any potential benefits. It must NEVER be used in the following cases:
These conditions require a careful risk-benefit analysis by a healthcare provider:
While pentazocine is chemically a benzomorphan, patients who have had severe anaphylactic reactions to other opioids (like morphine or codeine) should be monitored very closely, as cross-sensitivity, though rare, is theoretically possible. Furthermore, injectable forms containing sulfites must be avoided in patients with a known sulfite allergy, which is more common in individuals with asthma.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of lung disease or addiction, before prescribing Pentazocine.
Pentazocine is classified under FDA Pregnancy Category C (older system). There are no adequate and well-controlled studies in pregnant women.
Pentazocine is excreted in human milk in small amounts. Because of the potential for serious adverse reactions in nursing infants, including excess sedation and respiratory depression, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. If a nursing mother takes pentazocine, the infant must be closely monitored for increased sleepiness or breathing difficulties.
Safety and effectiveness in pediatric patients below the age of 12 have not been established. In adolescents over 12, the drug should be used with extreme caution. The primary concern in children is the risk of accidental overdose and the potential for increased sensitivity to the respiratory depressant effects of the drug.
Clinical studies of pentazocine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. However, clinical experience suggests that elderly patients are more prone to:
In patients with renal failure, the half-life of pentazocine metabolites is prolonged. While the clinical significance of these metabolites is not fully understood, they may contribute to CNS toxicity. Dosing intervals should be extended (e.g., every 6-8 hours instead of every 3-4 hours) in patients with a GFR below 30 mL/min.
This is a critical consideration for pentazocine. In patients with hepatic impairment (Child-Pugh Class B or C), the metabolism is severely slowed. This leads to much higher peak plasma levels and a longer duration of action. Healthcare providers must reduce the initial dose and monitor the patient for signs of over-sedation and respiratory distress.
> Important: Special populations require individualized medical assessment and frequent follow-up to ensure safety.
Pentazocine is a benzomorphan derivative that functions as a mixed opioid agonist-antagonist. Its primary analgesic action is mediated through its high affinity for the kappa (κ) opioid receptors located in the dorsal horn of the spinal cord and the brain. Stimulation of these receptors inhibits the release of neurotransmitters involved in pain signaling, such as Substance P.
Simultaneously, pentazocine acts as a weak antagonist or partial agonist at the mu (μ) opioid receptors. By binding to these receptors without fully activating them, it can block the effects of full mu-agonists. This explains why it has a "ceiling effect" for respiratory depression—meaning that after a certain dose, increasing the amount of drug does not further increase respiratory depression to the same extent as morphine—and why it can cause withdrawal in opioid-addicted individuals.
| Parameter | Value |
|---|---|
| Bioavailability | 18% - 50% (Oral) |
| Protein Binding | 60% |
| Half-life | 2 - 3 hours |
| Tmax | 1 - 3 hours (Oral); 15-60 min (IM) |
| Metabolism | Hepatic (Oxidation and Glucuronidation) |
| Excretion | Renal (60% within 24 hours) |
Pentazocine is the prototype of the benzomorphan class of opioids. It is therapeutically categorized as a mixed agonist-antagonist analgesic. Related medications include butorphanol and nalbuphine, which share similar mixed receptor profiles.
Common questions about Pentazocine
Pentazocine is a potent pain medication used to manage moderate to severe pain that cannot be controlled by non-opioid treatments. It is frequently used for acute pain following surgery or trauma, as well as for chronic pain conditions under strict medical supervision. Additionally, healthcare providers may use it as a preoperative medication to help sedate a patient before surgery or as a supplement during anesthesia to maintain pain control. Because it is a synthetic opioid with a unique mechanism of action, it is often chosen when other opioids might not be suitable or when a healthcare provider wants to minimize certain mu-receptor-related side effects. Always use this medication exactly as prescribed by your doctor.
The most common side effects associated with pentazocine include nausea, vomiting, dizziness, and a feeling of lightheadedness. Many patients also experience significant sedation or drowsiness, which can impair the ability to drive or perform complex tasks. Uniquely, because of its action on kappa receptors, pentazocine can cause dysphoria (a feeling of unease or dissatisfaction) or strange dreams and hallucinations. Other frequent issues include sweating, dry mouth, and constipation. While many of these symptoms improve as your body adjusts to the medication, constipation usually persists and may require management with stool softeners or dietary changes. If side effects become severe or bothersome, you should contact your healthcare provider.
No, you should never drink alcohol while taking pentazocine. Alcohol is a central nervous system (CNS) depressant, and when combined with an opioid like pentazocine, it can lead to dangerous and potentially fatal consequences. This combination significantly increases the risk of severe respiratory depression, which means your breathing may become dangerously slow or stop entirely. It can also cause extreme sedation, loss of consciousness, and coma. Even small amounts of alcohol found in over-the-counter cough and cold medicines should be avoided. If you have a history of alcohol use, discuss this with your doctor before starting pentazocine to ensure your safety.
Pentazocine is generally not recommended during pregnancy unless the potential benefits clearly outweigh the risks to the developing fetus. Long-term use of pentazocine during pregnancy can lead to Neonatal Opioid Withdrawal Syndrome (NOWS), a condition where the baby is born physically dependent on the drug and experiences withdrawal symptoms after birth. These symptoms can be life-threatening and require specialized medical care in a neonatal intensive care unit. Additionally, if used during labor, pentazocine can cause breathing difficulties in the newborn baby. If you are pregnant or planning to become pregnant, it is crucial to discuss alternative pain management strategies with your healthcare provider to protect your health and your baby's health.
The time it takes for pentazocine to start working depends on how it is administered. When taken as an oral tablet, pain relief typically begins within 15 to 30 minutes, with the full effect occurring about 1 to 3 hours after the dose. If given as an intramuscular (IM) injection, the onset is slightly faster, usually within 15 to 20 minutes. The fastest relief comes from an intravenous (IV) injection, which can begin working within 2 to 5 minutes. The effects of a single dose generally last for about 3 to 4 hours. Because the relief is relatively short-lived, the medication is often prescribed to be taken every 3 to 4 hours as needed for pain.
You should not stop taking pentazocine suddenly if you have been using it regularly for more than a few days. Doing so can trigger a withdrawal syndrome because your body has become physically dependent on the medication. Withdrawal symptoms can include anxiety, restlessness, sweating, chills, muscle aches, runny nose, and watery eyes. In some cases, more severe symptoms like abdominal cramps and diarrhea may occur. To avoid these uncomfortable and potentially dangerous effects, your doctor will provide a tapering schedule to gradually lower your dose over several days or weeks. Always follow your healthcare provider's instructions for stopping the medication safely.
If you miss a dose of pentazocine and you are taking it on a fixed schedule, take the missed dose as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed one and continue with your regular dosing plan. You should never take two doses at the same time to make up for a missed one, as this significantly increases the risk of an overdose and dangerous side effects like respiratory depression. If you are taking pentazocine only 'as needed' for pain, simply take the next dose when you feel pain, ensuring you maintain the minimum time interval (usually 3-4 hours) between doses recommended by your doctor.
Weight gain is not a commonly reported side effect of pentazocine. Unlike some other classes of medications, such as certain antidepressants or antipsychotics, opioids do not typically cause direct changes in metabolism that lead to weight gain. However, some patients might experience changes in weight indirectly. For example, the sedation and dizziness caused by the drug might lead to a more sedentary lifestyle, or the relief of chronic pain might improve appetite and lead to increased food intake. Conversely, some patients experience nausea and a loss of appetite, which could lead to weight loss. If you notice significant changes in your weight while taking this medication, discuss them with your healthcare provider.
Pentazocine has many potential drug interactions, some of which can be very serious. It should not be taken with other drugs that cause drowsiness or slow your breathing, such as benzodiazepines, sleep medications, or other opioids, unless specifically directed by your doctor. It also interacts dangerously with Monoamine Oxidase Inhibitors (MAOIs) used for depression. Because pentazocine has 'antagonist' properties, it can actually block the effects of other opioid pain relievers or cause withdrawal in people who take them regularly. Always provide your doctor and pharmacist with a complete list of all medications, herbal supplements, and vitamins you are taking to ensure there are no harmful interactions.
Yes, pentazocine is available as a generic medication in several forms. Generic versions are typically more affordable than the original brand-name drug, Talwin, which has been largely discontinued in its original single-ingredient oral form in the United States. The most common generic oral form is a combination of pentazocine and naloxone (generic for Talwin NX). Generic pentazocine lactate is also available for injection. Generic medications are required by the FDA to have the same active ingredient, strength, dosage form, and route of administration as the brand-name product, ensuring they provide the same clinical benefit and safety profile for patients.